Axsome Therapeutics

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell AXSM and other ETFs, options, and stocks.

About AXSM

Axsome Therapeutics, Inc. is a commercial-stage biopharmaceutical company, which engages in the development of novel therapies for the management of central nervous system disorders. Its portfolio consists of Products Overview and Pipeline Overview. 

CEO
Herriott Tabuteau
CEOHerriott Tabuteau
Employees
683
Employees683
Headquarters
New York, New York
HeadquartersNew York, New York
Founded
2012
Founded2012
Employees
683
Employees683

AXSM Key Statistics

Market cap
5.50B
Market cap5.50B
Price-Earnings ratio
-19.46
Price-Earnings ratio-19.46
Dividend yield
Dividend yield
Average volume
624.08K
Average volume624.08K
High today
$113.66
High today$113.66
Low today
$111.20
Low today$111.20
Open price
$113.06
Open price$113.06
Volume
443.15K
Volume443.15K
52 Week high
$139.13
52 Week high$139.13
52 Week low
$72.21
52 Week low$72.21

AXSM News

Simply Wall St 3d
Investors ignore increasing losses at Axsome Therapeutics as stock jumps 4.5% this past week

The worst result, after buying shares in a company (assuming no leverage), would be if you lose all the money you put in. But when you pick a company that is re...

Investors ignore increasing losses at Axsome Therapeutics as stock jumps 4.5% this past week

Analyst ratings

100%

of 19 ratings
Buy
100%
Hold
0%
Sell
0%

People also own

Based on the portfolios of people who own AXSM. This list is generated using Robinhood data, and it’s not a recommendation.
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer.